Flavopiridol (Alvocidib)
Catalog No. A10390
Flavopiridol(Alvocidib)是一种细胞周期蛋白依赖性激酶抑制剂,与ATP竞争性抑制CDK,包括CDK1, CDK2, CDK4和CDK6,CDK9。作用于CDK1, 2, 4, 6,9比作用于CDK7更具有选择性,用于治疗慢性淋巴细胞性白血病。
- Reiko Watanabe, .et al. Development of an In Silico Prediction Model for P-glycoprotein Efflux Potential in Brain Capillary Endothelial Cells toward the Prediction of Brain Penetration, J Med Chem, 2021, Mar 11;64(5):2725-2738 PMID: 33619967
- Zhiyuan Zhao, .et al. CDK9 and SPT5 proteins are specifically required for expression of herpes simplex virus 1 replication-dependent late genes, J Biol Chem, 2017, Sep 15; 292(37): 15489-15500 PMID: 28743741
- Sami Kukkonen, .et al. HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells, Retrovirology., 2014, 11: 30. PMID: 24742347
Catalog Num | A10390 |
---|---|
M. Wt | 401.8 |
Formula | C21H20ClNO5 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 146426-40-6 |
Synonyms | HMR-1275, L868275 |
SMILES | CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O |
Flavopiridol(Alvocidib)是一种细胞周期蛋白依赖性激酶抑制剂,与ATP竞争性抑制CDK,包括CDK1, CDK2, CDK4和CDK6,CDK9。作用于CDK1, 2, 4, 6,9比作用于CDK7更具有选择性,用于治疗慢性淋巴细胞性白血病。
Targets
CDK1 | CDK2 | CDK4 | CDK6 | CDK7 |
40 nM | 40 nM | 40 nM | 40 nM | 300 nM |
In vitro (25°C) | DMSO | 14 mg/mL (34.83 mM) | |
Water | Insoluble | ||
Ethanol | 7 mg/mL (17.41 mM) | ||
In vivo | 5% DMSO+30% PEG 300+ddH2O | 2.3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.89 mL | 124.44 mL | 248.88 mL |
0.5 mM | 4.98 mL | 24.89 mL | 49.78 mL |
1 mM | 2.49 mL | 12.44 mL | 24.89 mL |
5 mM | 0.5 mL | 2.49 mL | 4.98 mL |
*The above data is based on the productmolecular weight 401.8 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.